Check this out!
In the past weeks, LTR was only traded very cautiously on the German stock exchanges (on average 5000-10,000 shares/day).
Today, all dams are breaking by German standards:
Around 200,000 shares and disalloweds remain open for about 4 hours.
I'm aware that this is very little compared to the ASX, but by German standards this is an enormous increase in volume!
I'm firmly convinced that now everyone has understood that no CR is pending, that the unhealthily high proportion of short sellers makes a short squeeze more and more likely and the share price from now on only knows one direction...
I'm afraid that will be another short night for me when I look over to you to Australia ...
https://www.onvista.de/aktien/handelsplaetze/LIONTOWN-RESOURCES-Aktie-AU000000LTR4?notation=26114120&activeType=line&activeTab=J1&displayVolume=false&min=0&max=1569016799999&zoom=false&scaling=linear
- Forums
- ASX - By Stock
- LTR
- LTR: Short squeeze coming for shorters - 2nd highest likelihood in all ASX
LTR: Short squeeze coming for shorters - 2nd highest likelihood in all ASX, page-277
-
- There are more pages in this discussion • 3,847 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
97.0¢ | 97.5¢ | 96.0¢ | $1.845M | 1.905M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 445751 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 176844 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 420588 | 0.965 |
13 | 581855 | 0.960 |
20 | 777357 | 0.955 |
42 | 541063 | 0.950 |
10 | 109457 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 95809 | 15 |
0.980 | 169771 | 15 |
0.985 | 124988 | 9 |
0.990 | 122721 | 5 |
0.995 | 19776 | 4 |
Last trade - 10.30am 16/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online